Cargando…
Use of the interleukin 6 inhibitor tocilizumab in Japanese patients with cytokine release syndrome caused by COVID-19-related acute respiratory distress syndrome: A case series
Autores principales: | Nakamura, Hideta, Miyagi, Kazuya, Otsuki, Mariko, Higure, Yuuri, Nishiyama, Naoya, Kinjo, Takeshi, Nakamatsu, Masashi, Haranaga, Shusaku, Tateyama, Masao, Fujita, Jiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Respiratory Society. Published by Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7539801/ https://www.ncbi.nlm.nih.gov/pubmed/33067149 http://dx.doi.org/10.1016/j.resinv.2020.09.006 |
Ejemplares similares
-
Acute Hypertriglyceridaemia Caused by Tocilizumab in a Patient with Severe COVID-19
por: Nakamura, Hideta, et al.
Publicado: (2020) -
Case Report: Iliopsoas Hematoma during the Clinical Course of Severe COVID-19 in Two Male Patients
por: Nakamura, Hideta, et al.
Publicado: (2021) -
Case Report: Ischemic Enterocolitis Associated with Coronavirus Disease 2019: Two Case Reports and a Review of the Literature
por: Kinjo, Takeshi, et al.
Publicado: (2021) -
Human immunodeficiency virus‐associated pulmonary sarcoidosis in a Japanese man as a manifestation of immune reconstitution inflammatory syndrome
por: Nakamura, Hideta, et al.
Publicado: (2020) -
Use of steroids to treat anti-tumor necrosis factor α induced tuberculosis-associated immune reconstitution inflammatory syndrome: Case report and literature review
por: Nabeya, Daijiro, et al.
Publicado: (2020)